title: Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report.
authors.affiliation: Department of Pediatrics, University of Oklahoma Health Sciences Center.
authors.forename: Rachel
authors.initials: R
authors.lastname: Gallant
authors.affiliation: Department of Pediatrics, University of Oklahoma Health Sciences Center.
authors.forename: Phillip
authors.initials: P
authors.lastname: Bonney
authors.affiliation: Department of Pharmacy, OU Medical System.
authors.forename: Leigh
authors.initials: L
authors.lastname: Peek
authors.affiliation: Department of Pediatric Pathology, University of Oklahoma Health Sciences Center.
authors.forename: Zhongxin
authors.initials: Z
authors.lastname: Yu
authors.affiliation: Department of Pediatric Hematology-Oncology, University of Oklahoma Health Sciences Center.
authors.forename: David
authors.initials: D
authors.lastname: Crawford
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage*; D001228:Aspergillosis / Q000188:drug therapy* / Q000209:etiology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002648:Child; D006801:Humans; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000382:microbiology*; D065819:Voriconazole / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D011092:Polyethylene Glycols; C042705:pegaspargase; D001215:Asparaginase; D065819:Voriconazole